Does BIMEKIZUMAB-BKZX Cause Off label use? 335 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 335 reports of Off label use have been filed in association with BIMEKIZUMAB-BKZX. This represents 6.3% of all adverse event reports for BIMEKIZUMAB-BKZX.
335
Reports of Off label use with BIMEKIZUMAB-BKZX
6.3%
of all BIMEKIZUMAB-BKZX reports
3
Deaths
39
Hospitalizations
How Dangerous Is Off label use From BIMEKIZUMAB-BKZX?
Of the 335 reports, 3 (0.9%) resulted in death, 39 (11.6%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BIMEKIZUMAB-BKZX. However, 335 reports have been filed with the FAERS database.
What Other Side Effects Does BIMEKIZUMAB-BKZX Cause?
Product dose omission issue (694)
Psoriasis (621)
Drug ineffective (402)
Product availability issue (364)
Psoriatic arthropathy (301)
Injection site pain (263)
Therapy interrupted (252)
Hidradenitis (233)
Inappropriate schedule of product administration (214)
Incorrect dose administered (209)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which BIMEKIZUMAB-BKZX Alternatives Have Lower Off label use Risk?
BIMEKIZUMAB-BKZX vs BINIMETINIB
BIMEKIZUMAB-BKZX vs BIOFLAVONOIDS
BIMEKIZUMAB-BKZX vs BIOTIN
BIMEKIZUMAB-BKZX vs BIPERIDEN
BIMEKIZUMAB-BKZX vs BIRCH TRITERPENES